The risk for developing cardiovascular diseases (CVD) in rheumatoid arthritis (RA) patients
is 1.5 times higher compared to the general population. This risk is partly due to the …

Alopecia areata is an autoimmune hair loss disease that is non-scarring and is
characterized by chronic inflammation at the hair follicle level. Clinically, patients' …

Objectives To provide an integrated analysis of major adverse cardiovascular events
(MACEs) and events of venous thromboembolism (VTE) and associated risk factors across …

Deep Vein Thrombosis - Abstract - Europe PMC Sign in | Create an account https://orcid.org
Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog …

Objective In the ORAL (Oral Rheumatoid Arthritis triaL) Surveillance study of patients with
rheumatoid arthritis aged≥ 50 years with≥ 1 additional cardiovascular risk factor, incidence …

Janus kinases (JAKs) are central components in cytokine signaling pathways. A number of
small molecule JAK inhibitors have been approved to treat a wide range of inflammatory and …

Objectives Since 2010, biological disease‐modifying antirheumatic drugs (bDMARDs) have
been the dominant mode of treatment for rheumatoid arthritis (RA). However, the safety of …

Many epidemiological studies have shown an increased risk of venous thromboembolism
(VTE) in patients with rheumatoid arthritis (RA). RA and VTE share some background …

Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders of the
gastrointestinal tract including Crohn's disease and ulcerative colitis, which may result in …

Rheumatoid arthritis (RA) carries significant risk for atherosclerotic cardiovascular disease
(ASCVD). Traditional ASCVD risk factors fail to account for this accelerated atherosclerosis …